​​​​Jumbo phages are active against extensively-drug-resistant eyedrop-associated Pseudomonas aeruginosa infections​

May 8, 2023 | bioRxiv

Western firms are becoming interested in a Soviet medicine​

“Phage therapy” aims to use viruses to cure bacterial infections

May 3, 2023 | The Economist​​​

​​Antimicrobial Resistance: Examining an Emerging Public Health Threat​​

April 28, 2023 |​ ​Oversight and Investigations Subcommittee Hearing​

Phage Against the Routine: Resistant Acinetobacter​

February 28, 2023 |​ ​Superbugs & You

The promise of phages

May 9, 2023 |​ Nature Biotechnology

Babbage: How to battle superbugs with viruses

May 17, 2023 | Babbage from The Economist​

In the War on Bacteria, It’s Time to Call in the Phages

April 3, 2023 | WIRED

Therapeutic Potential of Intravenous Phage as Standalone Therapy for Recurrent Drug-Resistant Urinary Tract Infections

​​👋 Did You Know? 

82% of patients that have received phage therapy at UCSD have had a clinically successful outcome, the highest reported successful series in the US! Patients in San Diego, and across the globe, seek out UC San Diego School of Medicine’s Center for Innovative Phage Applications and Therapeutics (IPATH) because we are a leader in the fight against antibiotic-resistant infections. 

​With your support​, IPATH can increase the accessibility of phage therapy and offer hope to patients worldwide in their battle against antibiotic-resistant infections. #givingtuesday